UnicoCell

Home > News > Press Release

- Press Release
- Events

Press Release

2024-08-09 2024.08.09 Therapeutics Mechanism of UnicoCell's New Drug ELIXCYTE® Has Been Published Internationally
2024-08-06 2024.08.06 UnicoCell Biomed Concludes Phase 1/2 Chronic Kidney Disease Trial
2024-05-21 2024.05.21 UnicoCell Biomed (6794) was Publicly Listed on Taiwan Innovation Board
2024-05-14 2024.05.14 UnicoCell has passed the onsite inspection of cell processing facility from Japan MHLW (Ministry of Health, Labor and Welfare)
2024-04-18 2024.04.18 UnicoCell Biomed held a Pre-IPO Investor Conference on the TIB (Taiwan Innovation Board)
2024-02-17 2024.02.17 The stem cell new drug, ELIXCYTE, honored by the international journal Cytotherapy acceptance
2023-11-28 2023.11.28 UnicoCell, Taiwan Leading Company of Promising Allogeneic Stem Cell New Drug, applied to Taiwan Stock Exchange for IPO on Innovative Board
2023-11-09 2023.11.09 The Ministry of Health and Welfare approved the application for the RASMET in cooperation with the PaoChien Hospital.
2023-08-15 2023.8.15 UnicoCell received Acknowledgment letter of MF (Master File) from US FDA for UnicoCell Conditioned Medium (UCCM)
2023-07-10 2023.7.10 Unicocell Biomed Enrolls First Participant in Phase III Clinical Trial for Knee Osteoarthritis

«
1
2
3
4
»

1 page / total 4